Connection
Michael Szarek to Predictive Value of Tests
This is a "connection" page, showing publications Michael Szarek has written about Predictive Value of Tests.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.022 |
|
|
|
-
Reynolds SR, Vergilis IJ, Szarek M, Ferrone S, Bystryn JC. Cytoplasmic melanoma-associated antigen (CYT-MAA) serum level in patients with melanoma: a potential marker of response to immunotherapy? Int J Cancer. 2006 Jul 01; 119(1):157-61.
Score: 0.011
-
Schwartz GG, Olsson AG, Szarek M, Sasiela WJ. Relation of characteristics of metabolic syndrome to short-term prognosis and effects of intensive statin therapy after acute coronary syndrome: an analysis of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) trial. Diabetes Care. 2005 Oct; 28(10):2508-13.
Score: 0.011